ROCCI, LAURA
 Distribuzione geografica
Continente #
AS - Asia 1.885
NA - Nord America 140
EU - Europa 88
AF - Africa 5
SA - Sud America 4
OC - Oceania 1
Totale 2.123
Nazione #
SG - Singapore 1.770
US - Stati Uniti d'America 131
HK - Hong Kong 64
CN - Cina 42
IT - Italia 34
GB - Regno Unito 19
DE - Germania 14
CA - Canada 6
IN - India 5
NL - Olanda 5
EC - Ecuador 3
ES - Italia 3
FI - Finlandia 3
MX - Messico 3
FR - Francia 2
GH - Ghana 2
TR - Turchia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
IE - Irlanda 1
JP - Giappone 1
LU - Lussemburgo 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
UA - Ucraina 1
Totale 2.123
Città #
Hong Kong 62
Singapore 57
Boardman 29
Ashburn 27
Hefei 19
London 18
Shanghai 11
San Francisco 7
Milan 6
Toronto 6
Munich 5
Rome 5
Amsterdam 4
Council Bluffs 4
Pune 4
Canzo 3
Tivoli 3
Accra 2
Ancona 2
Boston 2
Brooklyn 2
Chieti 2
Florence 2
Hangzhou 2
Johannesburg 2
Los Angeles 2
Natick 2
Seattle 2
Turku 2
Washington 2
West Jordan 2
Andover 1
Ankara 1
Atlanta 1
Bethesda 1
Brno 1
Canberra 1
Cerveteri 1
Charlotte 1
Chengdu 1
Chennai 1
Dallas 1
Dongguan 1
Dubai 1
Dublin 1
Freetown 1
Helsinki 1
Juneau 1
Lancaster 1
Lianyun 1
Luxembourg 1
Melilli 1
Mexico City 1
Paris 1
Portici 1
Redmond 1
Redwood City 1
San Gavino Monreale 1
Santa Clara 1
Santa Teresa di Riva 1
Shijiazhuang 1
St Louis 1
São Paulo 1
Tokyo 1
Vienna 1
Warsaw 1
West Chester 1
Wuxi 1
Totale 335
Nome #
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 190
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 178
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 175
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 175
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 168
Docetaxel induced pericardial effusion 158
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 134
Scientific Evidence for Non-Pharmacological Management of the Main Side-Effects of Antineoplastic Drugs in Colorectal Cancer Patients. [Evidenze scientifiche per la gestione non farmacologica dei principali effetti collaterali della terapia antineoplastica nei pazienti con cancro colon-rettale] 108
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 100
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 99
Meeting information needs on cancer-related fatigue: an exploration of views held by Italian patients and nurses 85
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 84
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 83
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 81
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 72
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 71
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 63
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 58
Repeated intermittent low-dose therapy with zoledronic Acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients 46
Totale 2.128
Categoria #
all - tutte 9.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202257 0 0 5 1 1 2 2 4 2 3 3 34
2022/202318 4 1 6 0 0 0 0 2 2 1 2 0
2023/202487 4 8 2 11 8 30 1 12 1 4 2 4
2024/20251.958 13 7 34 5 7 33 9 6 37 120 733 954
2025/20268 8 0 0 0 0 0 0 0 0 0 0 0
Totale 2.128